25‑125 COVID‑19 tests25‑125 COVID‑19 tests

25‑125 COVID‑19 tests

(1) You can deduct a loss or outgoing to the extent it is incurred in gaining or producing your assessable income if: (a) you are an individual; and (b) the loss or outgoing is incurred in respect of testing you for the novel coronavirus SARS‑CoV‑2 that causes COVID‑19 using a test covered by subsection (3); and (c) the purpose of testing you is to determine whether you may attend or remain at a place where you: (i) engage in activities to gain or produce your assessable income; or (ii) engage in activities in the course of carrying on a *business for the purpose of gaining or producing your assessable income. (2) However, you cannot deduct a loss or outgoing under this section to the extent that it is a loss or outgoing of capital, or of a capital nature. (3) This subsection covers a test that: (a) is a polymerase chain reaction test; or (b) is a therapeutic good (within the meaning of the Therapeutic Goods Act 1989) that: (i) is included in the Australian Register of Therapeutic Goods maintained under section 9A of that Act; and (ii) has an intended purpose, accepted in relation to that inclusion, that relates to the detection of the novel coronavirus SARS‑CoV‑2 that causes COVID‑19.